Legend Biotech LEGN
NASDAQ LEGN
$18.63 -0.38 (-2.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) Construction in Progress (2018 - 2020)

Updated

Legend Biotech (LEGN) reported Construction in Progress of $33.64 million for Q4 2020, compared with $2.84 million a year earlier.

Analysis

Legend Biotech (LEGN) Construction in Progress (2018 - 2020) Analysis & Trends

  • By year, Construction in Progress came in at $2.84 million in FY2019 (+8.2%) and $2.63 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Legend Biotech 3.42 Bn 924.58 Mn 251.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 33.64 Mn
Dec 31, 2019 2.84 Mn
Dec 31, 2018 2.63 Mn
API Access

Legend Biotech Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=LEGN&period=max&api_key=YOUR_API_KEY